Refine
Has Fulltext
- yes (18)
Is part of the Bibliography
- yes (18)
Document Type
- Journal article (11)
- Conference Proceeding (4)
- Preprint (3)
Keywords
- Positronen-Emissions-Tomografie (14)
- PET (9)
- positron emission tomography (6)
- neuroendocrine tumor (5)
- RADS (3)
- SSTR (3)
- ageing (3)
- prostate cancer (3)
- somatostatin receptor (3)
- theranostics (3)
- 11C-HED (2)
- 18F-FDG (2)
- DaTscan (2)
- Ioflupane (2)
- PET/CT (2)
- PSMA (2)
- PSMA-RADS (2)
- Parkinson (2)
- Parkinson Disease (2)
- Parkinson-Krankheit (2)
- SPECT (2)
- [177Lu]-DOTATATE/-DOTATOC (2)
- [68Ga] (2)
- molecular imaging (2)
- personalized medicine (2)
- tumor heterogeneity (2)
- 11C-Hydroxyephedrine (1)
- 18F-DCFPyL (1)
- 18F-FDS (1)
- 18F-LMI1195 (1)
- 2-deoxy-2-(18F)fluoro-D-glucose (1)
- 2-deoxy-2-18F-fluoro-D-sorbitol (1)
- 68Ga-DOTANOC (1)
- 68Ga-DOTATATE (1)
- 68Ga-DOTATOC (1)
- AI (1)
- DCGAN (1)
- Diabetes (1)
- ECG (1)
- ECG-gated (1)
- EKG (1)
- FV45 (1)
- GAN (1)
- MI-RADS (1)
- MRI (1)
- Magnetresonanztomografie (1)
- Myokarditis (1)
- PROMISE (1)
- PRRT (1)
- Pancreas (1)
- Positron-Emission Tomography (1)
- SSTR-PET (1)
- SSTR-RADS (1)
- TKI (1)
- [68Ga]DOTATOC (1)
- angiotensin II type 1 receptor (1)
- artificial intelligence (1)
- cardiac sympathetic nervous system (1)
- diabetische Kardiomyopathie (1)
- heart failure (1)
- hydroxyephedrine (1)
- inflammation (1)
- interobserver (1)
- interreader (1)
- kidney (1)
- machine learning (1)
- magnetic resonance imaging (1)
- medullary thyroid carcinoma (1)
- moycardial sympathetic innervation (1)
- myocardial sympathetic innervation imaging (1)
- myocarditis (1)
- neuroendocrine neoplasia (1)
- pancreas (1)
- peptide receptor radionuclide therapy (1)
- personalized treatment (1)
- phaeochromocytoma (1)
- prostate-specific membrane antigen (1)
- prostate-specific membrane antigen (PSMA) (1)
- quantification (1)
- renal imaging (1)
- renin-angiotensin system (1)
- reporting and data system (1)
- reporting and data systems (1)
- somatostatin receptor (SSTR) (1)
- split renal function (1)
- standardization (1)
- standardized reporting (1)
- storage vesicle turnover (1)
- stroke (1)
- sympathetic nervous system (1)
- tyrosine kinase inhibitor (1)
- valsartan (1)
- vandetanib (1)
Institute
Sonstige beteiligte Institutionen
- Johns Hopkins School of Medicine (18) (remove)
EU-Project number / Contract (GA) number
- 701983 (18)
Objectives: Recently, the standardized reporting and data system for prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) imaging studies, termed PSMA-RADS version 1.0, was introduced. We aimed to determine the interobserver agreement for applying PSMA-RADS to imaging interpretation of 18F-DCFPyL PET examinations in a prospective setting mimicking the typical clinical work-flow at a prostate cancer referral center.
Methods: Four readers (two experienced readers (ER, > 3 years of PSMA-targeted PET interpretation experience) and two inexperienced readers (IR, < 1 year of experience)), who had all read the initial publication on PSMA-RADS 1.0, assessed 50 18F-DCFPyL PET/computed tomography (CT) studies independently. Per scan, a maximum of 5 target lesions were selected by the observers and a PSMA-RADS score for every target lesion was recorded. No specific pre-existing conditions were placed on the selection of the target lesions, although PSMA-RADS 1.0 suggests that readers focus on the most highly avid or largest lesions. An overall scan impression based on PSMA-RADS was indicated and interobserver agreement rates on a target lesion-based, on an organ-based, and on an overall PSMA-RADS score-based level were computed.
Results: The number of target lesions identified by each observer were as follows: ER 1, 123; ER 2, 134; IR 1, 123; and IR 2, 120. Among those selected target lesions, 125 were chosen by at least two individual observers (all four readers selected the same target lesion in 58/125 (46.4%) instances, three readers in 40/125 (32%) and two observers in 27/125 (21.6%) instances). The interobserver agreement for PSMA-RADS scoring among identical target lesions was good (intraclass correlation coefficient (ICC) for four, three and two identical target lesions, ≥0.60, respectively). For lymph nodes, an excellent interobserver agreement was derived (ICC=0.79). The interobserver agreement for an overall scan impression based on PSMA-RADS was also excellent (ICC=0.84), with a significant difference for ER (ICC=0.97) vs. IR (ICC=0.74, P=0.005).
Conclusions: PSMA-RADS demonstrates a high concordance rate in this study, even among readers with different levels of experience. This suggests that PSMA-RADS can be effectively used for communication with clinicians and can be implemented in the collection of data for large prospective trials.